Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

FDA Approves Rubraca, First PARP Inhibitor for Prostate Cancer

Hematology May 25th 2020

ASCO Offers Guidance on Resuming Cancer Care During COVID-19

Internal Medicine May 25th 2020

The New England Journal of Medicine

Anetumab Ravtansine Shows Encouraging Activity in Multiple Solid Tumor Types

Gastroenterology May 18th 2020

FDA Approves Selpercatinib as First Therapy for Certain Patients With Lung, Thyroid Cancers

Hematology May 18th 2020

COVID-19: US Scientists Identify 14 Vaccines to Focus On

Allergy & Immunology May 11th 2020

Letrozole Pre-Surgery Yields Drastic Biomarker Changes in ER+ DCIS

Internal Medicine May 11th 2020